Spironolactone is effective in treating hypokalemia among peritoneal dialysis patients.

about

Spironolactone is effective in treating hypokalemia among peritoneal dialysis patients.

Item

http://www.wikidata.org/entity/Q47134104

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Spironolactone is effective in treating hypokalemia among peritoneal dialysis patients.

@en

Spironolactone is effective in treating hypokalemia among peritoneal dialysis patients.

@nl

type

Item

label

Spironolactone is effective in treating hypokalemia among peritoneal dialysis patients.

@en

Spironolactone is effective in treating hypokalemia among peritoneal dialysis patients.

@nl

prefLabel

Spironolactone is effective in treating hypokalemia among peritoneal dialysis patients.

@en

Spironolactone is effective in treating hypokalemia among peritoneal dialysis patients.

@nl

P1476

Spironolactone is effective in treating hypokalemia among peritoneal dialysis patients.

@en

P2093

Amit Langote

http://www.w3.org/2001/XMLSchema#string

Marcel Ruzicka

http://www.w3.org/2001/XMLSchema#string

P2860

The Safety and Efficacy of Mineralocorticoid Receptor Antagonists in Patients Who Require Dialysis: A Systematic Review and Meta-analysis.

Long-term effects of spironolactone in peritoneal dialysis patients

Enhanced large intestinal potassium permeability in end-stage renal disease.

Effect of spironolactone on stool electrolyte losses during human cholera

Prevalence and pathogenesis of hypokalemia in patients on chronic peritoneal dialysis: one center's experience and review of the literature.

Serum potassium and cause-specific mortality in a large peritoneal dialysis cohort

Pathophysiology and management of hypokalemia: a clinical perspective.

Clinical Utility of Potassium-Sparing Diuretics to Maintain Normal Serum Potassium in Peritoneal Dialysis Patients.

Long-Term Effects of Low-Dose Spironolactone on Chronic Dialysis Patients: A Randomized Placebo-Controlled Study.

Hypokalaemia: an independent risk factor of Enterobacteriaceae peritonitis in CAPD patients.

P304

e0187269

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0187269

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Swapnil Hiremath

Brendan B McCormick

P577

2017-11-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29125879

http://www.w3.org/2001/XMLSchema#string

P932

5681284

http://www.w3.org/2001/XMLSchema#string